{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:20:32Z","timestamp":1787718032506,"version":"build-2784847793"},"reference-count":117,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ero.2025.11.025","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T19:33:47Z","timestamp":1770665627000},"page":"213-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recent developments in the use of biomarkers as diagnostic tools in patients with systemic lupus erythematosus: a narrative review"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1173-5937","authenticated-orcid":false,"given":"Tammo","family":"Brunekreef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henny","family":"Otten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Limper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ero.2025.11.025_bib0001","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 EULAR\/ACR classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ero.2025.11.025_bib0002","first-page":"74","article-title":"From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study","volume":"41","author":"Kapsala","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ero.2025.11.025_bib0003","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0961203320983445","article-title":"Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: cross sectional analysis of the LuLa cohort","volume":"30","author":"Kernder","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.11.025_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.890522","article-title":"Understanding the concept of pre-clinical autoimmunity: prediction and prevention of systemic lupus erythematosus: identifying risk factors and developing strategies against disease development","volume":"13","author":"Choi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0005","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ero.2025.11.025_bib0006","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar3258","article-title":"Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden","volume":"13","author":"Eriksson","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ero.2025.11.025_bib0007","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/rheumatology\/keab501","article-title":"Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody\u2013positive individuals","volume":"61","author":"Mu\u00f1oz-Grajales","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2025.11.025_bib0008","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1136\/annrheumdis-2015-208140","article-title":"Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification","volume":"75","author":"Munroe","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2025.11.025_bib0009","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaut.2016.06.001","article-title":"Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies","volume":"74","author":"Lu","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ero.2025.11.025_bib0010","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/0961203314523869","article-title":"Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosus","volume":"23","author":"Eriksson","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.11.025_bib0011","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/annrheumdis-2018-213386","article-title":"Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status","volume":"77","author":"Md Yusof","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2025.11.025_bib0012","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/ijcp.12466","article-title":"Development of SLE among \u201cpotential SLE\u201d patients seen in consultation: long-term follow-up","volume":"68","author":"Al Daabil","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ero.2025.11.025_bib0013","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/art.22665","article-title":"Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms","volume":"56","author":"Heinlen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ero.2025.11.025_bib0014","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1191\/096120300678828073","article-title":"Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus","volume":"9","author":"Vil\u00e1","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.11.025_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2249.2006.03251.x","article-title":"Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes","volume":"147","author":"Li","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0016","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar3927","article-title":"Autoantibody profiling to follow evolution of lupus syndromes","volume":"14","author":"Olsen","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ero.2025.11.025_bib0017","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s10020-018-0019-4","article-title":"Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus","volume":"24","author":"Bhattacharya","year":"2018","journal-title":"Mol Med"},{"key":"10.1016\/j.ero.2025.11.025_bib0018","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.40004","article-title":"Discerning risk of disease transition in relatives of systemic lupus erythematosus patients utilizing soluble mediators and clinical features","volume":"69","author":"Munroe","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ero.2025.11.025_bib0019","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1191\/0961203304lu477oa","article-title":"Outcome of incomplete systemic lupus erythematosus after 10 years","volume":"13","author":"Hallengren","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.11.025_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ero.2025.11.025_bib0021","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.imlet.2023.05.008","article-title":"Screening epitope peptides based on a phage-displayed random peptide and peptide microarrays to contribute to improving the diagnostic efficiency of systemic lupus erythematosus","volume":"259","author":"Li","year":"2023","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ero.2025.11.025_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109297","article-title":"Antibodies against neutrophil extracellular traps (NETs) potentiate clinical performance of anti-double-stranded DNA antibodies in systemic lupus erythematosus","volume":"249","author":"Zhan","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0023","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1093\/rheumatology\/keaa881","article-title":"Anti-NuMA antibodies: clinical associations and significance in patients with primary Sj\u00f6gren\u2019s syndrome or systemic lupus erythematosus","volume":"60","author":"Arcani","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2025.11.025_bib0024","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/art.42082","article-title":"Identification of mitofusin 1 and complement component 1q subcomponent binding protein as mitochondrial targets in systemic lupus erythematosus","volume":"74","author":"Becker","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ero.2025.11.025_bib0025","article-title":"Evaluation of serum Epstein-Barr virus envelope glycoproteins antibodies and their association with systemic autoimmune diseases","volume":"96","author":"Li","year":"2024","journal-title":"J Med Virol"},{"key":"10.1016\/j.ero.2025.11.025_bib0026","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ero.2025.11.025_bib0027","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/03009742.2024.2321700","article-title":"Immunoglobulin G\/immunoglobulin M autoantibody ratios in incomplete systemic lupus erythematosus","volume":"53","author":"Henning","year":"2024","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ero.2025.11.025_bib0028","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/BOR.0000000000000922","article-title":"An update on autoantibodies in systemic lupus erythematosus","volume":"35","author":"G\u00f3mez-Ba\u00f1uelos","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ero.2025.11.025_bib0029","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41580-023-00615-w","article-title":"The technological landscape and applications of single-cell multi-omics","volume":"24","author":"Baysoy","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ero.2025.11.025_bib0030","doi-asserted-by":"crossref","first-page":"7506","DOI":"10.3390\/ijms22147506","article-title":"The potential of OMICs technologies for the treatment of immune-mediated inflammatory diseases","volume":"22","author":"Anchang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ero.2025.11.025_bib0031","doi-asserted-by":"crossref","unstructured":"Lindblom J, Beretta L, Borghi MO, PRECISESADS Clinical Consortium, Alarc\u00f3n-Riquelme ME, Parodis I. Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus. Front Immunol. 2023;14:1257085.","DOI":"10.3389\/fimmu.2023.1257085"},{"key":"10.1016\/j.ero.2025.11.025_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1830431","article-title":"Efficiency of disease and disease activity diagnosis models of systemic lupus erythematosus based on protein array analysis","volume":"2022","author":"Zhao","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ero.2025.11.025_bib0033","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/08820139.2022.2134024","article-title":"Semaphorin 4A as a potential biomarker for diagnosis of systemic Lupus erythematosus","volume":"52","author":"He","year":"2023","journal-title":"Immunol Invest"},{"key":"10.1016\/j.ero.2025.11.025_bib0034","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.936534","article-title":"Serum calprotectin - a NET product - as a biomarker of disease activity in patients with systemic lupus erythematosus: a single-center case-control study from Poland","volume":"28","author":"Homa-Mlak","year":"2022","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ero.2025.11.025_bib0035","doi-asserted-by":"crossref","DOI":"10.1177\/03946320231154988","article-title":"High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus","volume":"37","author":"Kamel","year":"2023","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.ero.2025.11.025_bib0036","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1177\/09612033211035508","article-title":"Expression of caveolin family proteins in serum of patients with systemic lupus erythematosus","volume":"30","author":"Li","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.11.025_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1403104","article-title":"PSGL-1, ADAM8, and selectins as potential biomarkers in the diagnostic process of systemic lupus erythematosus and systemic sclerosis: an observational study","volume":"15","author":"San Antonio","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0038","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/1756-185X.14360","article-title":"Increased levels of sirtuin-1 in systemic lupus erythematosus","volume":"25","author":"Yang","year":"2022","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.ero.2025.11.025_bib0039","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1093\/rheumatology\/keab875","article-title":"Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus","volume":"61","author":"Zorn-Pauly","year":"2022","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.ero.2025.11.025_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105381","article-title":"Persistent low complement levels and increased interferon gene expression are predictive for disease progression in patients with incomplete systemic lupus erythematosus","volume":"89","author":"Lambers","year":"2022","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ero.2025.11.025_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109155","article-title":"Potential biomarkers for diagnosis and assessment of disease activity in systemic lupus erythematosus","volume":"111","author":"Zhang","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ero.2025.11.025_bib0042","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1471-4914(03)00071-6","article-title":"The role of selectins in inflammation and disease","volume":"9","author":"Ley","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ero.2025.11.025_bib0043","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/rheumatology\/ket342","article-title":"Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis","volume":"53","author":"Xiong","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2025.11.025_bib0044","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrm3314","article-title":"Metabolomics: the apogee of the omic triology","volume":"13","author":"Patti","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ero.2025.11.025_bib0045","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/joim.13596","article-title":"Blood metabolite profiles linking dietary patterns with health\u2014Toward precision nutrition","volume":"293","author":"Noerman","year":"2023","journal-title":"J Intern Med"},{"key":"10.1016\/j.ero.2025.11.025_bib0046","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11882-014-0445-5","article-title":"Metabolomics approach in allergic and rheumatic diseases","volume":"14","author":"Scrivo","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.ero.2025.11.025_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109330","article-title":"Serum proteome and metabolome uncover novel biomarkers for the assessment of disease activity and diagnosing of systemic lupus erythematosus","volume":"251","author":"He","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0048","article-title":"Serum metabolic fingerprints characterize systemic lupus erythematosus","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.ero.2025.11.025_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110235","article-title":"Targeted metabolomics combined with machine learning to identify and validate new biomarkers for early SLE diagnosis and disease activity","volume":"264","author":"Liang","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0050","first-page":"1011","article-title":"Untargeted lipidomics reveals specific lipid abnormalities in systemic lupus erythematosus","volume":"40","author":"Wang","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ero.2025.11.025_bib0051","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/rheumatology\/keaa126","article-title":"Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus","volume":"60","author":"Zhang","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2025.11.025_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109057","article-title":"Integration of metabolomics and lipidomics reveals serum biomarkers for systemic lupus erythematosus with different organs involvement","volume":"241","author":"Zhang","year":"2022","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0053","article-title":"Combined proteomics and single cell RNA-sequencing analysis to identify biomarkers of disease diagnosis and disease exacerbation for systemic lupus erythematosus","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0054","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cca.2022.06.031","article-title":"TMT-based quantitative proteomics analysis and potential serum protein biomarkers for systemic lupus erythematosus","volume":"534","author":"Zhou","year":"2022","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ero.2025.11.025_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1369385","article-title":"Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response","volume":"15","author":"Kim","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0056","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1177\/09612033211014268","article-title":"Urine \u03b2-2-glycoprotein 1 as a biomarker for diagnosis of systemic lupus erythematosus","volume":"30","author":"Lee","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.11.025_bib0057","article-title":"S100A8 in serum, urine, and saliva as a potential biomarker for systemic lupus erythematosus","volume":"13","author":"Kim","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0058","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000562","article-title":"ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies","volume":"8","author":"Chen","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ero.2025.11.025_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1289124","article-title":"Gut microbiota landscape and potential biomarker identification in female patients with systemic lupus erythematosus using machine learning","volume":"13","author":"Song","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ero.2025.11.025_bib0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/cells11020236","article-title":"S100A8\/A9 is a marker for the release of neutrophil extracellular traps and induces neutrophil activation","volume":"11","author":"Sprenkeler","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ero.2025.11.025_bib0061","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.vetmic.2014.04.016","article-title":"Escherichia fergusonii","volume":"172","author":"Gaastra","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.ero.2025.11.025_bib0062","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ero.2025.11.025_bib0063","doi-asserted-by":"crossref","first-page":"10025","DOI":"10.1007\/s11033-023-08845-z","article-title":"Serum miRNA-21, miRNA-146a and plasma cell free DNA as novel biomarkers for assessing systemic lupus erythematosus activity","volume":"50","author":"Ibrahim","year":"2023","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.ero.2025.11.025_bib0064","doi-asserted-by":"crossref","first-page":"e3326","DOI":"10.1002\/jgm.3326","article-title":"Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis","volume":"23","author":"Abdul-Maksoud","year":"2021","journal-title":"J Gene Med"},{"key":"10.1016\/j.ero.2025.11.025_bib0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2007.03.008","article-title":"miR-181a is an intrinsic modulator of T cell sensitivity and selection","volume":"129","author":"Li","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ero.2025.11.025_bib0066","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nature06607","article-title":"Regulation of progenitor cell proliferation and granulocyte function by microRNA-223","volume":"451","author":"Johnnidis","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ero.2025.11.025_bib0067","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clinbiochem.2022.05.004","article-title":"Novel microRNA biomarkers of systemic lupus erythematosus in plasma: miR-124-3p and miR-377-3p","volume":"107","author":"Yan","year":"2022","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ero.2025.11.025_bib0068","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fbioe.2020.00276","article-title":"Dysregulation of signaling pathways due to differentially expressed genes from the B-Cell transcriptomes of systemic lupus erythematosus patients - a bioinformatics approach","volume":"8","author":"Udhaya Kumar","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.ero.2025.11.025_bib0069","article-title":"miR-183-5p is a potential molecular marker of systemic lupus erythematosus","volume":"2021","author":"Zhou","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ero.2025.11.025_bib0070","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.immuni.2016.05.015","article-title":"The MicroRNA-183-96-182 cluster promotes T helper 17 cell pathogenicity by negatively regulating transcription factor Foxo1 expression","volume":"44","author":"Ichiyama","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ero.2025.11.025_bib0071","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40364-021-00272-1","article-title":"miR-21: a non-specific biomarker of all maladies","volume":"9","author":"Jenike","year":"2021","journal-title":"Biomark Res"},{"key":"10.1016\/j.ero.2025.11.025_bib0072","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12929-019-0523-z","article-title":"The emerging roles and functions of circular RNAs and their generation","volume":"26","author":"Yu","year":"2019","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.ero.2025.11.025_bib0073","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3892\/mmr.2021.12256","article-title":"circPTPN22 as a novel biomarker and ceRNA in peripheral blood mononuclear cells of rheumatoid arthritis","volume":"24","author":"Jiang","year":"2021","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.ero.2025.11.025_bib0074","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13075-023-03150-3","article-title":"CircPTPN22 modulates T-cell activation by sponging miR-4689 to regulate S1PR1 expression in patients with systemic lupus erythematosus","volume":"25","author":"Jiang","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ero.2025.11.025_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2020.11639","article-title":"Expression profile and diagnostic value of circRNAs in peripheral blood from patients with systemic lupus erythematosus","volume":"23","author":"Luo","year":"2021","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.ero.2025.11.025_bib0076","doi-asserted-by":"crossref","DOI":"10.1080\/1547691X.2023.2196453","article-title":"Hsa_circ_0044235 and hsa_circ_0001947 as novel biomarkers in plasma of patients with new-onset systemic lupus erythematosus","volume":"20","author":"Luo","year":"2023","journal-title":"J Immunotoxicol"},{"key":"10.1016\/j.ero.2025.11.025_bib0077","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s13258-022-01315-z","article-title":"Circular RNA expression profile of systemic lupus erythematosus and its clinical significance as a potential novel biomarker","volume":"44","author":"Li","year":"2022","journal-title":"Genes Genom"},{"key":"10.1016\/j.ero.2025.11.025_bib0078","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1177\/09612033231207545","article-title":"Downregulation of circETS1 disrupts Th17\/Treg homeostasis by inhibiting FOXP3 transcription: a new potential biomarker in systemic lupus erythematosus","volume":"32","author":"Ma","year":"2023","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.11.025_bib0079","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ero.2025.11.025_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148713","article-title":"Differential lncRNA profiles of blood plasma-derived exosomes from systemic lupus erythematosus","volume":"927","author":"Peng","year":"2024","journal-title":"Gene"},{"key":"10.1016\/j.ero.2025.11.025_bib0081","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.615859","article-title":"Integrated transcriptome profiling revealed that elevated long non-coding RNA-AC007278.2 expression repressed CCR7 transcription in systemic lupus erythematosus","volume":"12","author":"You","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0082","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-001065","article-title":"Novel potential lncRNA biomarker in B cells indicates essential pathogenic pathway activation in patients with SLE","volume":"11","author":"Zhu","year":"2024","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ero.2025.11.025_bib0083","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/apm.13410","article-title":"LncRNA SNHG1 serves as a biomarker for systemic lupus erythematosus and participates in the disease progression","volume":"132","author":"Jiang","year":"2024","journal-title":"APMIS"},{"key":"10.1016\/j.ero.2025.11.025_bib0084","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268176","article-title":"The potential role of serum expression profile of long non coding RNAs, Cox2 and HOTAIR as novel diagnostic biomarkers in systemic lupus erythematosus","volume":"17","author":"Mahmoud","year":"2022","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ero.2025.11.025_bib0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11845-023-03420-8","article-title":"NR_103776.1 as a novel diagnostic biomarker for systemic lupus erythematosus","volume":"193","author":"Wang","year":"2024","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.ero.2025.11.025_bib0086","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/09612033241243175","article-title":"Serum long non-coding ribonucleic acid H19 serves as a biomarker for systemic lupus erythematosus and participates in the disease progression","volume":"33","author":"Yang","year":"2024","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.11.025_bib0087","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/8564650","article-title":"Integrative bioinformatics analysis identifies DDX60 as a potential biomarker for systemic lupus erythematosus","volume":"2023","author":"Chen","year":"2023","journal-title":"Dis Markers"},{"key":"10.1016\/j.ero.2025.11.025_bib0088","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cca.2021.11.003","article-title":"The role of cyclic GMP-AMP synthase and Interferon-I-inducible protein 16 as candidate biomarkers of systemic lupus erythematosus","volume":"524","author":"Fu","year":"2022","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ero.2025.11.025_bib0089","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.978851","article-title":"MX2: identification and systematic mechanistic analysis of a novel immune-related biomarker for systemic lupus erythematosus","volume":"13","author":"Meng","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.962393","article-title":"Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus","volume":"13","author":"Shen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0091","article-title":"The shared circulating diagnostic biomarkers and molecular mechanisms of systemic lupus erythematosus and inflammatory bowel disease","volume":"15","author":"Sun","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0092","article-title":"Identification of key biomarkers in systemic lupus erythematosus by a multi-cohort analysis","volume":"13","author":"Wei","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0093","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s10067-024-06881-z","article-title":"Identification of EPSTI1 as a new potential biomarker for SLE based on GEO database","volume":"43","author":"Yang","year":"2024","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ero.2025.11.025_bib0094","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s10067-022-06495-3","article-title":"Identification of potential biomarkers for systemic lupus erythematosus by integrated analysis of gene expression and methylation data","volume":"42","author":"Zhang","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ero.2025.11.025_bib0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12967-020-02698-x","article-title":"Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis","volume":"19","author":"Zhao","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.ero.2025.11.025_bib0096","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12865-023-00581-0","article-title":"Exploration of biomarkers for systemic lupus erythematosus by machine-learning analysis","volume":"24","author":"Zhao","year":"2023","journal-title":"BMC Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0097","article-title":"Screening biomarkers for systemic lupus erythematosus based on machine learning and exploring their expression correlations with the ratios of various immune cells","volume":"13","author":"Zhong","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0098","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41467-023-36306-5","article-title":"Multi-ancestry and multi-trait genome-wide association meta-analyses inform clinical risk prediction for systemic lupus erythematosus","volume":"14","author":"Khunsriraksakul","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ero.2025.11.025_bib0099","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002687","article-title":"Interferon signature in systemic autoimmune diseases: what does it mean?","volume":"8","author":"Nocturne","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.ero.2025.11.025_bib0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1404260","article-title":"Genetically predicted associations between circulating cytokines and autoimmune diseases: a bidirectional two-sample Mendelian randomization","volume":"15","author":"Jie","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ero.2025.11.025_bib0102","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/09612033241241850","article-title":"Significant heightened methylation levels of RUNX3 gene promoter in patients with systemic lupus erythematosus","volume":"33","author":"Ehtesham","year":"2024","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.11.025_bib0103","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1007\/s10067-023-06736-z","article-title":"Demethylation of CDKN2A in systemic lupus erythematosus and rheumatoid arthritis: a blood biomarker for diagnosis and assessment of disease activity","volume":"42","author":"Gravand","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ero.2025.11.025_bib0104","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0092-8674(02)00690-6","article-title":"Causal relationship between the loss of RUNX3 expression and gastric cancer","volume":"109","author":"Li","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ero.2025.11.025_bib0105","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1158\/0008-5472.CAN-06-0369","article-title":"RUNX3 Is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer","volume":"66","author":"Lau","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ero.2025.11.025_bib0106","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clim.2016.08.010","article-title":"Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis","volume":"185","author":"Mistry","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0107","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/s41591-022-02014-8","article-title":"Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome","volume":"28","author":"Chen","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ero.2025.11.025_bib0108","doi-asserted-by":"crossref","DOI":"10.1038\/srep15954","article-title":"Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects","volume":"5","author":"Bordag","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ero.2025.11.025_bib0109","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001152","article-title":"Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: a systematic review and meta-analysis","volume":"11","author":"Wong","year":"2024","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ero.2025.11.025_bib0110","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41581-023-00732-x","article-title":"Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants","volume":"19","author":"Vinuesa","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ero.2025.11.025_bib0111","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ero.2025.11.025_bib0112","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fimmu.2013.00142","article-title":"The interferon-signature of Sj\u00f6gren\u2019s syndrome: how unique biomarkers can identify underlying inflammatory and immunopathological mechanisms of specific diseases","volume":"4","author":"Nguyen","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0113","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103025","article-title":"Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus","volume":"136","author":"Lindblom","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ero.2025.11.025_bib0114","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.866319","article-title":"A systematic review of the progression of cutaneous lupus to systemic lupus erythematosus","volume":"13","author":"Curtiss","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.11.025_bib0115","article-title":"Role of biomarkers in the diagnosis and prognosis of patients with cutaneous lupus erythematosus","volume":"9","author":"Zhu","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ero.2025.11.025_bib0116","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semarthrit.2020.11.006","article-title":"From incomplete to complete systemic lupus erythematosus; a review of the predictive serological immune markers","volume":"51","author":"Lambers","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ero.2025.11.025_bib0117","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125001247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125001247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T03:51:58Z","timestamp":1787716318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708125001247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":117,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S3050708125001247"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2025.11.025","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent developments in the use of biomarkers as diagnostic tools in patients with systemic lupus erythematosus: a narrative review","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}